Cargando…
Exosomal miR‐21/Let‐7a ratio distinguishes non‐small cell lung cancer from benign pulmonary diseases
AIM: To assess the exosomal miR‐21/Let‐7a ratio, a noninvasive method, in distinguishing non‐small cell lung cancer (NSCLC) from benign pulmonary diseases. METHODS: The exosomes were extracted from the peripheral blood serum using serum exosomal extraction kit. miR‐21 and Let‐7a levels were evaluate...
Autores principales: | Yang, Guofeng, Wang, Tao, Qu, Xiangyun, Chen, Shuchen, Han, Ziyang, Chen, Sui, Chen, Mingduan, Lin, Jihong, Yu, Shaobin, Gao, Lei, Peng, Kaiming, Kang, Mingqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496917/ https://www.ncbi.nlm.nih.gov/pubmed/32525285 http://dx.doi.org/10.1111/ajco.13343 |
Ejemplares similares
-
The role of EEF1D in disease pathogenesis: a narrative review
por: Xu, Hui, et al.
Publicado: (2021) -
Single-direction VATS left lower lobectomy and lymph node dissection after neoadjuvant chemotherapy combined with immunotherapy: a case report
por: Lin, Jihong, et al.
Publicado: (2021) -
Safety and economic analysis of the EasyEndo disposable endoscopic cutting and stapling device for VATS lobectomy or segmentectomy in lung cancer patients: a retrospective study
por: Han, Ziyang, et al.
Publicado: (2023) -
Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease
por: Işın, Mustafa, et al.
Publicado: (2015) -
Predictive nomogram for postoperative atrial fibrillation in locally advanced esophageal squamous carcinoma cell with neoadjuvant treatment
por: Fang, Meiqin, et al.
Publicado: (2023)